Clinicien(ne) chercheur(e)

Dr Robert De Larochellière

Cardiologie

robert.de-larochelliere@criucpq.ulaval.ca

Publications

Trier par année :

Bertrand OF, De Larochellière R, Tessier M. Trans-radial three vessel brachytherapy in a single session. J Invasive Cardiol 2003; 0(15):457-59.
Bertrand OF, De Larochellière R, Rodés-Cabau J, Proulx G, Gleeton O, Nguyen CM, Déry JP, Barbeau G, Noël B, Larose E, Poirier P, Roy L. A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation.. Circulation 2006; 114(24):2636-43.
Potvin JM, Rodés-Cabau J, Bertrand OF, Gleeton O, Nguyen CN, Barbeau G, Proulx G, De Larochellière R, Déry JP, Batalla N, Dana A, Facta A, Roy L. Usefulness of fractional flow reserve measurements to defer revascularization in patients with stable or unstable angina pectoris, non-ST-elevation and ST-elevation acute myocardial infarction, or aty. Am J Cardiol 2006; 98(3):289-97.
Garceau P, Déry JP, Lachance P, Grenier S, Rodés-Cabau J, Barbeau G, Bertrand OF, Gleeton O, Larose E, Nguyen CM, Noël B, Proulx G, Roy L, de Larochellière R. Treatment delays in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction at the Quebec Heart and Lung Institute.. Can J Cardiol 2007; 23(0):53-57B.
Bertrand OF, Faurie B, Larose E, Nguyen CM, Gleeton O, Déry JP, Noël B, Proulx G, Roy L, Costerousse O, De Larochellière R, Rodes-Cabau J. Clinical Outcomes after Multilesion Percutaneous Coronary Intervention: Comparison between Exclusive and Selective Use of Drug-Eluting Stents.. J Invasive Cardiol 2008; 20(3):99-104.
Nissen SE, Nicholls SJ, Wolski K, Nesto R, Kupfer S, Perez A, Jure H, De Larochellière R, Staniloae CS, Mavromatis K, Saw J, Hu B, Lincoff AM, Tuzcu EM. Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial.. JAMA 2008; 299(13):1561-73.
Bertrand OF, Larose E, Rodés-Cabau J, Gleeton O, Taillon I, Roy L, Poirier P, Costerousse O, De Larochellière RD. Incidence, predictors, and clinical impact of bleeding after transradial coronary stenting and maximal antiplatelet therapy.. Am Heart J 2009; 157(1):164-9.
Clavel MA, Dumont E, Pibarot P, Doyle D, De Larochellière R, Villeneuve J, Bergeron S, Couture C, Rodés-Cabau J. Severe valvular regurgitation and late prosthesis embolization after percutaneous aortic valve implantation.. Ann Thorac Surg 2009; 87(2):618-21.
Tizón-Marcos H, Bertrand OF, Rodés-Cabau J, Larose E, Gaudreault V, Bagur R, Gleeton O, Courtis J, Roy L, Poirier P, Costerousse O, De Larochellière R. Impact of female gender and transradial coronary stenting with maximal antiplatelet therapy on bleeding and ischemic outcomes.. Am Heart J 2009; 157(4):740-5.
Bagur RH, Doyle D, Dumont É, De Larochellière R, Lemieux J, Bergeron S, Gingras JL, Bertrand OF, Pibarot P, Rodés-Cabau J. Transapical Aortic Valve Implantation in a Patient With Severe Aortic Stenosis and Pott Disease.. Circulation 2009; 120(16):e140-2.
Bertrand OF, Rodés-Cabau J, Larose E, Nguyen CM, Déry JP, Proulx G, Roy L, Poirier P, Costerousse O, De Larochellière R. Effects of intracoronary compared to intravenous abciximab administration in patients undergoing transradial percutaneous coronary intervention: A sub-analysis of the EASY trial.. Int J Cardiol 2009; 136(2):165-70.
Dumont E, Rodés-Cabau J, De LaRochellière R, Lemieux J, Villeneuve J, Doyle D. Rapid pacing technique for preventing ventricular tears during transapical aortic valve replacement.. J Card Surg 2009; 24(3):295-8.
Tizón-Marcos H, De Larochellière R, Larose E. Breakpoint: left main stent fracture--review of the literature.. J Interv Cardiol 2009; 22(4):362-7.
Bagur R, Bertrand OF, Rodés-Cabau J, Rinfret S, Larose E, Tizón-Marcos H, Gleeton O, Nguyen CM, Roy L, Costerousse O, De Larochellière R. Comparison of outcomes in patients > or =70 years versus <70 years after transradial coronary stenting with maximal antiplatelet therapy for acute coronary syndrome.. Am J Cardiol 2009; 104(5):624-9.
Bertrand OF, Rodés-Cabau J, Rinfret S, Larose E, Bagur R, Proulx G, Gleeton O, Costerousse O, De Larochellière R, Roy L. Impact of final activated clotting time after transradial coronary stenting with maximal antiplatelet therapy.. Am J Cardiol 2009; 104(9):1235-40.
Clavel MA, Webb JG, Pibarot P, Altwegg L, Dumont E, Thompson C, De Larochellière R, Doyle D, Masson JB, Bergeron S, Bertrand OF, Rodés-Cabau J. Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis.. J Am Coll Cardiol 2009; 53(20):1883-91.
Bertrand OF, Poirier P, Rodés-Cabau J, Rinfret S, Title L, Dzavik V, Natarajan M, Angel J, Batalla N, Alméras N, Costerousse O, De Larochellière R, Roy L, Després JP, . A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial.. Can J Cardiol 2009; 25(9):509-15.
Larose E, Proulx G, Voisine P, Rodés-Cabau J, De Larochellière R, Rossignol G, Bertrand OF, Tremblay JP. Percutaneous versus surgical delivery of autologous myoblasts after chronic myocardial infarction: an in vivo cardiovascular magnetic resonance study.. Catheter Cardiovasc Interv 2010; 75(1):120-7.
Bagur R, Dumont E, Doyle D, Larose E, Lemieux J, Bergeron S, Bilodeau S, Bertrand OF, De Larochellière R, Rodés-Cabau J. Coronary ostia stenosis after transcatheter aortic valve implantation.. JACC Cardiovasc Interv 2010; 3(2):253-5.
Larose E, Tizon-Marcos H, Rodés-Cabau J, Rinfret S, Déry JP, Nguyen CM, Gleeton O, Boudreault JR, Roy L, Noël B, Proulx G, Rouleau J, Barbeau G, De Larochellière R, Bertrand OF.. Improving myocardial salvage in late presentation acute ST-elevation myocardial infarction with proximal embolic protection.. Catheter Cardiovasc Interv 2010; 76(4):461-70.
Bagur R, Webb JG, Nietlispach F, Dumont E, De Larochellière R, Doyle D, Masson JB, Gutiérrez MJ, Clavel MA, Bertrand OF, Pibarot P, Rodés-Cabau J. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement.. Eur Heart J 2010; 31(7):865-74.
Bertrand OF, Larose E, Rodés-Cabau J, Rinfret S, Déry JP, Bagur R, Gleeton O, Nguyen CM, Proulx G, De Larochellière R, Poirier P, Costerousse O, Roy L.. Incidence, range, and clinical effect of hemoglobin changes within 24 hours after transradial coronary stenting.. Am J Cardiol 2010; 106(2):155-61.
Bertrand OF, Poirier P, Rodés-Cabau J, Rinfret S, Title LM, Dzavik V, Natarajan M, Angel J, Batalla N, Alméras N, Costerousse O, De Larochellière R, Roy L, Després JP; VICTORY Trial Investigators.. Cardiometabolic effects of rosiglitazone in patients with type 2 diabetes and coronary artery bypass grafts: A randomized placebo-controlled clinical trial.. Atherosclerosis 2010; 211(2):565-73.
Larose E, Rodés-Cabau J, Pibarot P, Rinfret S, Proulx G, Nguyen CM, Déry JP, Gleeton O, Roy L, Noël B, Barbeau G, Rouleau J, Boudreault JR, Amyot M, De Larochellière R, Bertrand OF. Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction: Traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance.. J Am Coll Cardiol 2010; 55(22):2459-69.
Bertrand OF, Rodés-Cabau J, Larose E, Rinfret S, Gaudreault V, Proulx G, Barbeau G, Déry JP, Gleeton O, Manh-Nguyen C, Noël B, Roy L, Costerousse O, De Larochellière R (EArly Discharge after Transradial Stenting of CoronarY Arteries in Acute Myocardial Infarction (EASY-MI) Study Investigators). Intracoronary compared to intravenous Abciximab and high-dose bolus compared to standard dose in patients with ST-segment elevation myocardial infarction undergoing transradial primary percutaneous coronary intervention: a two-by-two factorial placebo-controlled randomized study.. Am J Cardiol 2010; 105(11):1520-7.
Clavel MA, Webb JG, Rodés-Cabau J, Masson JB, Dumont E, De Larochellière R, Doyle D, Bergeron S, Baumgartner H, Burwash IG, Dumesnil JG, Mundigler G, Moss R, Kempny A, Bagur R, Bergler-Klein J, Gurvitch R, Mathieu P, Pibarot P. Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction.. Circulation 2010; 122(19):1928-36.
Bagur R, Rodés-Cabau J, Doyle D, De Larochellière R, Villeneuve J, Bertrand OF, Dumont E. Transcatheter aortic valve implantation with "no touch" of the aortic arch for the treatment of severe aortic stenosis associated with complex aortic atherosclerosis.. J Card Surg 2010; 25(5):501-3.
Bertrand OF, Larose E, Costerousse O, Mongrain R, Rodés-Cabau J, Déry JP, Nguyen CM, Barbeau G, Gleeton O, Proulx G, De Larochellière R, Noël B, Roy L. Effects of aspiration thrombectomy on necrosis size and ejection fraction after transradial percutaneous coronary intervention in acute ST-elevation myocardial infarction.. Catheter Cardiovasc Interv 2011; 77(4):475-82.
Bagur R, Rodés-Cabau J, Doyle D, De Larochellière R, Villeneuve J, Lemieux J, Bergeron S, Côté M, Bertrand OF, Pibarot P, Dumont E. Usefulness of TEE as the primary imaging technique to guide transcatheter transapical aortic valve implantation.. JACC Cardiovasc Imaging 2011; 4(2):115-24.
Bagur R, Rodés-Cabau J, Dumont E, De Larochellière R, Doyle D, Pibarot P, Côté M, Clavel MA, Villeneuve J, Gutiérrez M, Poirier P, Bertrand OF. Performance-based functional assessment of patients undergoing transcatheter aortic valve implantation.. Am Heart J 2011; 161(4):726-34.
Rodés-Cabau J, Dumont E, Boone RH, Larose E, Bagur R, Gurvitch R, Bédard F, Doyle D, De Larochellière R, Jayasuria C, Villeneuve J, Marrero A, Côté M, Pibarot P, Webb JG. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches.. J Am Coll Cardiol 2011; 57(1):18-28.
Rodés-Cabau J, Gutiérrez M, Bagur R, De Larochellière R, Doyle D, Côté M, Villeneuve J, Bertrand OF, Larose E, Manazzoni J, Pibarot P, Dumont E.. Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation.. J Am Coll Cardiol 2011; 57(20):1988-99.
Rodés-Cabau J, Gutiérrez M, Courtis J, Larose É, Déry JP, Côté M, Nguyen CM, Gleeton O, Proulx G, Roy L, Noël B, Barbeau G, De Larochellière R, Rinfret S, F Bertrand OF. Importance of Diffuse Atherosclerosis in the Functional Evaluation of Coronary Stenosis in the Proximal-Mid Segment of a Coronary Artery by Myocardial Fractional Flow Reserve Measurements.. Am J Cardiol 2011; 108(4):483-90.
Clavel MA, Rodés-Cabau J, Dumont É, Bagur R, Bergeron S, De Larochellière R, Doyle D, Larose E, Dumesnil JG, Pibarot P. Validation and characterization of transcatheter aortic valve effective orifice area measured by Doppler echocardiography.. JACC Cardiovasc Imaging 2011; 4(10):1053-62.
Bagur R, Rodés-Cabau J, De Larochellière R, Doyle D, Rheault M, Dumont E. Transfemoral aortic valve-in-valve implantation with a balloon-expandable valve for the treatment of stentless xenograft severe aortic regurgitation.. JACC Cardiovasc Interv 2011; 4(11):1248-9.
Bagur R, Gleeton O, Rinfret S, De Larochellière R, Bertrand OF, Rodés-Cabau J. Transradial extra deep coronary intubation with a guide catheter for direct thromboaspiration in acute myocardial infarction.. Int J Cardiol 2012; 158(2):e32-4.
Kalavrouziotis D, Rodés-Cabau J, Bagur R, Doyle D, De Larochellière R, Pibarot P, Dumont E. Transcatheter aortic valve implantation in patients with severe aortic stenosis and small aortic annulus.. J Am Coll Cardiol 2011; 58(10):1016-24.
Payne DM, Rodes-Cabau J, Doyle D, De Larochellière R, Villeneuve J, Dumont E. Prominent Septal Hypertrophy: A Contra-Indication for Transapical Aortic Valve Implantation?. J Card Surg 2012; 27(3):309-11.
Bagur R, Dumont É, Doyle D, De Larochellière R, Rodés-Cabau J. Transcatheter aortic valve-in-valve-in-valve implantation for a failed xenograft.. Ann Thorac Surg 2012; 93(2):647-50.
Bagur R, Rodés-Cabau J, Dumont E, De Larochellière R, Doyle D, Bertrand OF, Côté M, Poirier P, Pibarot P. Exercise capacity in patients with severe symptomatic aortic stenosis before and six months after transcatheter aortic valve implantation.. Am J Cardiol 2011; 108(2):258-64.
Binder RK, Rodés-Cabau J, Wood DA, Mok M, Leipsic J, De Larochellière R, Toggweiler S, Dumont E, Freeman M, Willson AB, Webb JG. Transcatheter Aortic Valve Replacement With the SAPIEN 3: A New Balloon-Expandable Transcatheter Heart Valve.. JACC Cardiovasc Interv 2013; 6(3):293-300.
Plourde G, Abdelaal E, Bataille Y, Machaalany J, Déry JP, Déry U, Larose E, De Larochellière R, Gleeton O, Barbeau G, Roy L, Costerousse O, Bertrand OF. Effect on Door-to-Balloon Time of Immediate Transradial Percutaneous Coronary Intervention on Culprit Lesion in ST-Elevation Myocardial Infarction Compared to Diagnostic Angiography Followed by Primary Percutaneous Coronary Intervention.. Am J Cardiol 2013; 111(6):836-40.
Rinfret S, Rodés-Cabau J, Bagur R, Déry JP, Dorais M, Larose E, Barbeau G, Gleeton O, Nguyen CM, Noël B, Proulx G, Roy L, Taillon I, De Larochellière R, Bertrand OF. Telephone contact to improve adherence to dual antiplatelet therapy after drug-eluting stent implantation.. Heart 2013; 99(8):562-9.
Mok M, Nombela-Franco L, Urena M, De Larochellière R, Doyle D, Ribeiro HB, Côté M, Pibarot P, Delarochellière H, Laflamme L, Poirier P, Dumont E, Rodés-Cabau J. Prognostic value of exercise capacity as evaluated by the 6-minute walk test in patients undergoing transcatheter aortic valve implantation.. J Am Coll Cardiol 2013; 61(8):897-8.
Nombela-Franco L, Ruel M, Radhakrishnan S, Webb JG, Hansen M, Labinaz M, Thompson C, Fremes S, Dumont E, De Larochellière R, Doyle D, Urena M, Mok M, Ribeiro HB, Roifman I, Watkins S, Dumesnil JG, Pibarot P, Rodés-Cabau J. Comparison of Hemodynamic Performance of Self-Expandable CoreValve Versus Balloon-Expandable Edwards SAPIEN Aortic Valves Inserted by Catheter for Aortic Stenosis.. Am J Cardiol 2013; 111(7):1026-33.
Nombela-Franco L, Rodés-Cabau J, De Larochelliere R, Larose É, Doyle D, Villeneuve J, Bergeron S, Bernier M, Amat-Santos I, Mok M, Urena M, Rheault M, Dumesnil JG, Côté M, Pibarot P, Dumont É. Predictive Factors, Efficacy and Safety of Balloon Post-Dilation following Transcatheter Aortic Valve Implantation with a Balloon-Expandable Valve.. JACC Cardiovasc Interv 2012; 5(5):499-512.
Amat-Santos IJ, Rodés-Cabau J, Urena M, De Larochellière R, Doyle D, Bagur R, Villeneuve J, Côté M, Nombela-Franco L, Philippon F, Pibarot P, Dumont E. Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation.. J Am Coll Cardiol 2012; 59(2):178-88.
Urena M, Nombela-Franco L, Doyle D, De Larochellière R, Dumont E, Villeneuve J, Pasian SM, Gingras M, Mok M, Rodés-Cabau J. Transcatheter aortic valve implantation for the treatment of surgical valve dysfunction ("valve-in-valve"): assessing the risk of coronary obstruction.. J Card Surg 2012; 27(6):682-5.
Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Osten M, Feindel CM, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson M, Thompson CR, Wood D, Toggweiler S, Gurvitch R, Lichtenstein SV, Doyle D, De Larochellière R, Teoh K, Chu V, Bainey K, Lachapelle K, Cheema A, Latter D, Dumesnil JG, Pibarot P, Horlick E. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience.. J Am Coll Cardiol 2012; 60(19):1864-75.
Urena M, Mok M, Serra V, Dumont E, Nombela-Franco L, De Larochellière R, Doyle D, Igual A, Larose E, Amat-Santos I, Côté M, Cuéllar H, Pibarot P, de Jaegere P, Philippon F, Garcia del Blanco B, Rodés-Cabau J. Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve.. J Am Coll Cardiol 2012; 60(18):1743-52.
Amat-Santos IJ, Dumont E, Villeneuve J, Doyle D, Rheault M, Lavigne D, Lemieux J, St-Pierre A, Mok M, Urena M, Nombela-Franco L, Blackburn S, Simon M, Bourgault C, Carrasco JL, Pibarot P, Côté M, De Larochellière R, Cohen DJ, Rodés-Cabau J. Effect of thoracic epidural analgesia on clinical outcomes following transapical transcatheter aortic valve implantation.. Heart 2012; 98(21):1583-90.
Bagur R, Rodés-Cabau J, Gurvitch R, Dumont É, Velianou JL, Manazzoni J, Toggweiler S, Cheung A, Ye J, Natarajan MK, Bainey KR, De Larochellière R, Doyle D, Pibarot P, Voisine P, Côté M, Philippon F, Webb JG. Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings.. JACC Cardiovasc Interv 2012; 5(5):540-51.
MacHaalany J, Abdelaal E, Bataille Y, Plourde G, Duranleau-Gagnon P, Larose É, Déry JP, Barbeau G, Rinfret S, Rodés-Cabau J, De Larochellière R, Roy L, Costerousse O, Bertrand OF. Benefit of bivalirudin versus heparin after transradial and transfemoral percutaneous coronary intervention.. Am J Cardiol 2012; 110(12):1742-8.
Bataille Y, Déry JP, Larose E, Déry U, Costerousse O, Rodés-Cabau J, Rinfret S, De Larochellière R, Abdelaal E, Machaalany J, Barbeau G, Roy L, Bertrand OF. Prevalence, predictors and clinical impact of unique and multiple chronic total occlusion in non-infarct-related artery in patients presenting with ST-elevation myocardial infarction.. Heart 2012; 98(23):1732-7.
Mok M, Urena M, Nombela-Franco L, Ribeiro HB, Allende R, De Larochellière R, Doyle D, Dumont E, Côté M, Rodés-Cabau J. Clinical and prognostic implications of existing and new-onset atrial fibrillation in patients undergoing transcatheter aortic valve implantation.. J Thromb Thrombolysis 2013; 35(4):450-5.
Le Ven F, Freeman M, Webb J, Clavel MA, Wheeler M, Dumont E, Thompson C, De Larochellière R, Moss R, Doyle D, Ribeiro HB, Alcazar MU, Nombela-Franco L, Rodés-Cabau J, Pibarot P.. Impact of Low Flow on the Outcome of High Risk Patients Undergoing Transcatheter Aortic Valve Replacement.. J Am Coll Cardiol 2013; 62(9):782-8.
Ribeiro HB, Doyle D, Nombela-Franco L, Urena M, Allende R, De Larochellière R, Rodés-Cabau J, Dumont E.. Transapical Implantation of the SAPIEN 3 Valve.. J Card Surg 2013; 28(5):506-9.
Nombela-Franco L, Barbosa Ribeiro H, Allende R, Urena M, Doyle D, Dumont E, De Larochellière R, Rodés-Cabau J.. Role of balloon postdilation following trancatheter aortic valve implantation.. Minerva Cardioangiol Eur 2013; 61(5):499-12.
Mok M, Nombela-Franco L, Dumont E, Urena M, De Larochellière R, Doyle D, Villeneuve J, Côté M, Ribeiro HB, Allende R, Laflamme J, De Larochellière H, Laflamme L, Amat-Santos I, Pibarot P, Maltais F, Rodés-Cabau J.. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers and functional status changes.. JACC Cardiovasc Interv 2013; 6(10):1072-84.
Abdelaal E, Plourde G, Machaalany J, Arsenault J, Rimac G, Déry JP, Barbeau G, Larose E, De Larochellière R, Nguyen CM, Allende R, Ribeiro H, Costerousse O, Mongrain R, Bertrand OF. Effectiveness of Low Rate Fluoroscopy at Reducing Operator and Patient Radiation Dose During Transradial Coronary Angiography and Interventions.. JACC Cardiovasc Interv 2014; 7(5):567-74.
Allende R, Ribeiro HB, Puri R, Urena M, Abdul-Jawad O, Del Trigo M, Veiga G, Del Rosario Ortas M, Paradis JM, De Larochellière R, Rodés-Cabau J. The transradial approach during transcatheter structural heart disease interventions: a review.. Eur J Clin Invest 2015; 45(2):215-25.
Harvey A, Modak A, Déry U, Roy M, Rinfret S, Bertrand OF, Larose É, Rodés-Cabau J, Barbeau G, Gleeton O, Nguyen CM, Proulx G, Noël B, Roy L, Paradis JM, De Larochellière R, Déry JP. Changes in CYP2C19 enzyme activity evaluated by the [(13)C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity.. J Breath Res 2016; 10(1):017104.
De Larochellière H, Urena M, Amat-Santos IJ, Ribeiro HB, Allende R, Laflamme L, Laflamme J, Paradis JM, Dumont E, Doyle D, Mohammadi S, De Larochellière R, Côté M, Laroche V, Rodés-Cabau J. Effect on outcomes and exercise performance of anemia in patients with aortic stenosis who underwent transcatheter aortic valve replacement.. Am J Cardiol 2015; 115(4):472-9.
Allende R, Doyle D, Urena M, Ribeiro HB, Amat-Santos IJ, Bernier M, Pasian S, De Larochellière R, Dumont E, Rodés-Cabau J. Transcatheter Mitral "Valve-in-Ring" Implantation: A Word of Caution.. Ann Thorac Surg 2015; 99(4):1439-42.
Amat-Santos IJ, Ribeiro HB, Urena M, Allende R, Houde C, Bédard E, Perron J, De Larochellière R, Paradis JM, Dumont E, Doyle D, Mohammadi S, Côté M, San Roman JA, Rodés-Cabau J. Prosthetic valve endocarditis after transcatheter valve replacement: a systematic review.. JACC Cardiovasc Interv 2015; 8(2):334-46.
Laflamme J, Puri R, Urena M, Laflamme L, De Larochellière H, Abdul-Jawad Altisent O, Del Trigo M, Campelo-Parada F, De Larochellière R, Paradis JM, Dumont E, Doyle D, Mohammadi S, Côté M, Pibarot P, Laroche V, Rodés-Cabau J. Incidence and Risk Factors of Hemolysis After Transcatheter Aortic Valve Implantation With a Balloon-Expandable Valve.. Am J Cardiol 2015; 115(11):1574-9.
Ribeiro HB, Larose É, de la Paz Ricapito M, Le Ven F, Nombela-Franco L, Urena M, Allende R, Amat-Santos I, Dahou A, Capoulade R, Clavel MA, Mohammadi S, Paradis JM, De Larochellière R, Doyle D, Dumont É, Pibarot P, Rodés-Cabau J. Myocardial injury following transcatheter aortic valve implantation: insights from delayed-enhancement cardiovascular magnetic resonance.. EuroIntervention 2015; 11(2):205-13.
Le Ven F, Thébault C, Dahou A, Ribeiro HB, Capoulade R, Mahjoub H, Urena M, Nombela-Franco L, Allende Carrera R, Clavel MA, Dumont É, Dumesnil J, De Larochellière R, Rodés-Cabau J, Pibarot P. Evolution and prognostic impact of low flow after transcatheter aortic valve replacement.. Heart 2015; 101(15):1196-203.
Bertrand OF, Ruzsa Z, Barria Perez A, De Larochellière R. Same-Day Discharge After Transradial Percutaneous Coronary Intervention and Carotid Stenting in a Single Session.. Can J Cardiol 2017; 33(6):830.e1-830.
Paradis JM, White JM, Généreux P, Urena M, Doshi D, Nazif T, Hahn R, George I, Khalique O, Harjai K, Lasalle L, Labbé BM, De Larochellière R, Doyle D, Dumont E, Mohammadi S, Leon MB, Rodés-Cabau J, Kodali S. Impact of Coronary Artery Disease Severity Assessed With the SYNTAX Score on Outcomes Following Transcatheter Aortic Valve Replacement.. J Am Heart Assoc 2017; 6(2):e005070.
Rodés-Cabau J, Jolly SS, Cairns J, Mansour S, L'Allier PL, Teefy PJ, Graham JJ, Le May MR, Cantor WJ, Wood D, Balasubramanian K, De Larochellière R, Dzavik V. Sealing Intermediate Nonobstructive Coronary Saphenous Vein Graft Lesions With Drug-Eluting Stents as a New Approach to Reducing Cardiac Events: A Randomized Controlled Trial.. Circ Cardiovasc Interv 2016; 9(11):e004336.
Auffret V, Becerra Munoz V, Loirat A, Dumont E, Le Breton H, Paradis JM, Doyle D, De Larochellière R, Mohammadi S, Verhoye JP, Dagenais F, Bedossa M, Boulmier D, Leurent G, Asmarats L, Regueiro A, Chamandi C, Rodriguez-Gabella T, Voisine E, Moisan AS, Thoenes M, Côté M, Puri R, Voisine P, Rodés-Cabau J. Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Lower-Surgical-Risk Patients With Chronic Obstructive Pulmonary Disease.. Am J Cardiol 2017; 120(10):1863-8.
Urena M, Del Trigo M, Altisent OA, Campelo-Prada F, Regueiro A, De Larochellière R, Doyle D, Mohammadi S, Paradis JM, Dagenais F, Dumont E, Puri R, Laroche V, Rodés-Cabau J. Combined erythropoietin and iron therapy for anaemic patients undergoing transcatheter aortic valve implantation: the EPICURE randomised clinical trial.. EuroIntervention 2017; 13(1):44-52.
Abdul-Jawad Altisent O, Puri R, Regueiro A, Chamandi C, Rodriguez-Gabella T, Del Trigo M, Campelo-Parada F, Couture T, Marsal JR, Côté M, Paradis JM, De Larochellière R, Doyle D, Mohammadi S, Dumont E, Rodés-Cabau J. Predictors and Association With Clinical Outcomes of the Changes in Exercise Capacity After Transcatheter Aortic Valve Replacement.. Circulation 2017; 136(7):632-643.
Huynh T, Montigny M, Iftikhar U, Gagnon R, Eisenberg M, Lauzon C, Mansour S, Rinfret S, Afilalo M, Nguyen M, Kouz S, Déry JP, Harvey R, De Larochellière R, Cantin B, Schampaert E, Tardif JC. Recurrent Cardiovascular Events in Survivors of Myocardial Infarction With ST-Segment Elevation (from the AMI-QUEBEC Study).. Am J Cardiol 2018; 121(8):897-902.
Maes F, Costerousse O, Cieza T, Henry M, Déry JP, Barbeau G, De Larochellière R, Paradis JM, Larose E, Nguyen CM, Pirlet C, Mongrain R, Bertrand OF. Transradial experience with bioresorbable vascular scaffolds: A case-matched study with metallic drug-eluting stents.. Cardiovasc Revasc Med 2018; 19(6):700-704.
Salaun E, Zenses AS, Clavel MA, Rodriguez-Gabella T, Dumont E, Mohammadi S, Doyle D, Paradis JM, De Larochelliere R, Pibarot P, Rodés-Cabau J. Valve-in-Valve Procedure in Failed Transcatheter Aortic Valves.. JACC Cardiovasc Imaging 2019; 12(1):198-202.
Zenses AS, Dahou A, Salaun E, Clavel MA, Rodés-Cabau J, Ong G, Guzzetti E, Côté M, De Larochellière R, Paradis JM, Doyle D, Mohammadi S, Dumont É, Chamandi C, Rodriguez-Gabella T, Rieu R, Pibarot P. Haemodynamic outcomes following aortic valve-in-valve procedure.. Open Heart 2018; 5(2):e000854.
Chamandi C, Abi-Akar R, Rodés-Cabau J, Blanchard D, Dumont E, Spaulding C, Doyle D, Pagny JY, De Larochellière R, Lafont A, Paradis JM, Puri R, Karam N, Maes F, Rodriguez-Gabella T, Chassaing S, Le Page O, Kalavrouziotis D, Mohammadi S.. Transcarotid Compared With Other Alternative Access Routes for Transcatheter Aortic Valve Replacement.. Circ Cardiovasc Interv 2018; 11(11):e006388.
Abellas-Sequeiros RA, Benezet J, Agarrado Luna A, Oneto Otero J, Déry JP, Cieza T, De Larochellière R, Duocastella L, Gomez A, Molina M, Asmarats L, Pelletier-Beaumont E, Puri R, Rodés-Cabau J.. Percutaneous coronary intervention for treating de-novo lesions in small coronary vessels: initial experience with the Essential paclitaxel-coated balloon.. Coron Artery Dis 2018; 29(6):477-481.
Chamandi C, Mohammadi S, Dumont E, Doyle D, De Larochellière R, Paradis JM, Puri R, Pasian S, Pelletier-Beaumont É, Rodés-Cabau J. Cerebral Embolism Following Transcarotid Transcatheter Aortic Valve Replacement.. J Am Coll Cardiol 2018; 71(1):101-102.
Vilalta V, Asmarats L, Ferreira-Neto AN, Maes F, de Freitas Campos Guimarães L, Couture T, Paradis JM, Mohammadi S, Dumont E, Kalavrouziotis D, De Larochellière R, Rodés-Cabau J.. Incidence, Clinical Characteristics, and Impact of Acute Coronary Syndrome Following Transcatheter Aortic Valve Replacement.. JACC Cardiovasc Interv 2018; 11(24):2523-2533.
Campelo-Parada F, Nombela-Franco L, Urena M, Regueiro A, Jiménez-Quevedo P, Del Trigo M, Chamandi C, Rodríguez-Gabella T, Auffret V, Abdul-Jawad Altisent O, De Larochellière R, Paradis JM, Dumont E, Philippon F, Pérez-Castellano N, Puri R, Macaya C, Rodés-Cabau J. Timing of Onset and Outcome of New Conduction Abnormalities Following Transcatheter Aortic Valve Implantation: Role of Balloon Aortic Valvuloplasty.. Rev Esp Cardiol (Engl Ed) 2018; 71(3):162-169.
Faroux L, Junquera L, Mohammadi S, Kalavrouziotis D, Dumont E, Paradis JM, De Larochellière R, Del Val D, Muntané-Carol G, Pasian S, Ferreira-Neto A, Pelletier-Beaumont E, Rodés-Cabau J. Cerebral Embolism Following Transcarotid TAVR:Factors Associated with Ipsilateral Ischemic Burden.. Ann Thorac Surg 2021; 111(3):951-957.
Porterie J, Kalavrouziotis D, Dumont E, Paradis JM, De Larochellière R, Rodés-Cabau J, Mohammadi S. Clinical impact of the heart team on the outcomes of surgical aortic valve replacement among octogenarians.. J Thorac Cardiovasc Surg 2023; 165(3):1010-1019.e5.
Valle FH, Goodman SG, Tan M, Ha A, Mansour S, Welsh RC, Yan AT, Bainey KR, Rinfret S, Potter BJ, Khan R, Simkus G, Natarajan MK, Schwalm JD, Daneault B, Eisenberg MJ, Abunassar J, Har B, Gregoire J, Tanguay JF, Overgaard CB, Dery JP, De Larochelliere R, Paradis JM, Madan M, Elbarouni B, So DYF, Quraishi AU, Bagai A. Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: Findings From the CONNECT AF+PCI Study.. CJC Open 2021; 3(12):1419-1427.
Pascual I, Hernández-Vaquero D, Alperi A, Almendarez M, Avanzas P, Kalavrouziotis D, Lorca R, Mesnier J, Arboine L, Mohammadi S, Valle RD, Dumont E, Leon V, De Larochelliere R, Rodés-Cabau J, Moris C. Permanent Pacemaker Reduction Using Cusp-Overlapping Projection in TAVR: A Propensity Score Analysis.. JACC Cardiovasc Interv 2022; 15(2):150-161.
Nuche J, Panagides V, Nault I, Mesnier J, Paradis JM, de Larochellière R, Kalavrouziotis D, Dumont E, Mohammadi S, Philippon F, Rodés-Cabau J. Incidence and clinical impact of tachyarrhythmic events following transcatheter aortic valve replacement: A review.. Heart Rhythm 2022; 19(11):1890-1898.
Rodés-Cabau J, Ibrahim R, De Larochellière R, Ben Ali W, Paradis JM, Robichaud S, Dorval JF, Mohammadi S, Dumont E, Kalavrouziotis D, Mesnier J, Panagides V, Picard-Deland M, Lalancette S, Pelletier-Beaumont E. A pressure wire for rapid pacing, valve implantation and continuous haemodynamic monitoring during transcatheter aortic valve implantation procedures.. EuroIntervention 2022; 18(4):e345-e348.
Hecht S, Zenses AS, Bernard Jm Tastet L, Côté N, de Freitas Campos Guimaraes L, Paradis JM, Beaudoin J, O'Connor K, Bernier M, Dumont É, Kalavrouziotis D, De Larochellière R, Mohammadi S, Clavel MA, Rodés-Cabau J, Salaun E, Pibarot P.. Hemodynamic and Clinical Outcomes in Redo-Surgical Aortic Valve Replacement vs. Transcatheter Valve-in-Valve.. Struct Heart 2022; 6(6):100106.
Keller LS, Nuche J, Mesnier J, Farjat-Pasos J, Paradis JM, De Larochellière R, Mohammadi S, Kalavrouziotis D, Dumont E, Philippon F, Rodés-Cabau J.. Syncope in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.. Can J Cardiol 2023; 39(7):901-908.
Nuche J, Masso van-Roessel A, Nault I, Paradis JM, de Larochellière R, Mesnier J, Champagne J, Mohammadi S, Philippon F, Rodés-Cabau J. Temporary active fixation lead pacemaker in transcatheter aortic valve replacement patients with right bundle branch block.. Heart Rhythm 2023; 20(2):309-310.
Chow JK, Bagai A, Tan MK, Har BJ, Yip AMC, Paniagua M, Elbarouni B, Bainey KR, Paradis JM, Maranda R, Cantor WJ, Eisenberg MJ, Dery JP, Madan M, Cieza T, Matteau A, Roth S, Lavi S, Glanz A, Gao D, Tahiliani R, Welsh RC, Kim HH, Robinson SD, Daneault B, Chong AY, Le May MR, Ahooja V, Gregoire JC, Nadeau PL, Laksman Z, Heilbron B, Yung D, Minhas K, Bourgeois R, Overgaard CB, Bonakdar H, Logsetty G, Lavoie AJ, De LaRochelliere R, Mansour S, Spindler C, Yan AT, Goodman SG. Antithrombotic therapies in Canadian atrial fibrillation patients with concomitant coronary artery disease: Insights from the CONNECT AF?+?PCI-II program.. J Cardiol 2023; 82(2):153-161.
Keller LS, Nuche J, Avvedimento M, Real C, Pasos JF, Paradis JM, De Larochellière R, Poulin A, Kalavrouziotis D, Dumont E, Galhardo A, Mengi S, Mohammadi S, Cabau JR. Angina in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.. Rev Esp Cardiol (Engl Ed) 2023; 0(0):Epub.
Real C, Avvedimento M, Nuche J, Franzone A, Farjat-Pasos J, Trinh KH, De Larochellière R, Paradis JM, Poulin A, Dumont E, Kalavrouziotis D, Mohammadi S, Mengi S, Esposito G, Rodés-Cabau J. Myocardial Injury After Transcatheter Aortic Valve Replacement According to VARC-3 Criteria.. JACC Cardiovasc Interv 2023; 16(10):1221-1232.
Benseba J, Mercier J, Couture T, Faroux L, Bernatchez L, Côté M, Panagides V, Mesnier J, Mohammadi S, Dumont É, Kalavrouziotis D, Hadjadj S, Beaudoin J, De Larochellière R, Rodés-Cabau J, Paradis JM. Fractional Flow Reserve to Assess Coronary Artery Disease in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation: Long-Term Outcomes.. Struct Heart 2023; 7(4):100179.
Avvedimento M, Real C, Nuche J, Farjat-Pasos J, Galhardo A, Trinh KH, Robichaud M, De Larochellière R, Paradis JM, Poulin A, Dumont E, Kalavrouziotis D, Mohammadi S, Côté M, Rodés-Cabau J. Incidence, Predictors, and Prognostic Impact of Bleeding Events After TAVR According to VARC-3 Criteria.. JACC Cardiovasc Interv 2023; 16(18):2262-2274.

Dr Robert De Larochellière

Publications

Soutenir la médecine de demain, maintenant.

Soutenir la médecine
de demain, maintenant.